Literature DB >> 14643619

In vivo behavior of three different injectable hydraulic calcium phosphate cements.

D Apelt1, F Theiss, A O El-Warrak, K Zlinszky, R Bettschart-Wolfisberger, M Bohner, S Matter, J A Auer, B von Rechenberg.   

Abstract

Two dicalcium phosphate dihydrate (DCPD) hydraulic cements and one apatite hydraulic cement were implanted in epiphyseal and metaphyseal, cylindrical bone defects of sheep. The in vivo study was performed to assess the biocompatibility of the DCPD cements, using the apatite cement as control. After time periods of 2, 4 and 6 months the cement samples were clinically and histologically evaluated. Histomorphometrically the amount of new bone formation, fibrous tissue and the area of remaining cement were measured over time. In all specimens, no signs of inflammation were detectable either macroscopically or microscopically. All cements were replaced by different amounts of new bone. The two DCPD-cements showed the highest new bone formation and least cement remnants at 6 months, whereas the apatite was almost unchanged over all time periods.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14643619     DOI: 10.1016/j.biomaterials.2003.08.073

Source DB:  PubMed          Journal:  Biomaterials        ISSN: 0142-9612            Impact factor:   12.479


  45 in total

1.  A novel sheep vertebral bone defect model for injectable bioactive vertebral augmentation materials.

Authors:  X S Zhu; Z M Zhang; H Q Mao; D C Geng; J Zou; G L Wang; Z G Zhang; J H Wang; L Chen; H L Yang
Journal:  J Mater Sci Mater Med       Date:  2010-12-03       Impact factor: 3.896

2.  In-situ hardening hydroxyapatite-based scaffold for bone repair.

Authors:  Yu Zhang; Hockin H K Xu; Shozo Takagi; Laurence C Chow
Journal:  J Mater Sci Mater Med       Date:  2006-05       Impact factor: 3.896

3.  In vivo evaluation of an injectable Macroporous Calcium Phosphate Cement.

Authors:  Sergio del Valle; Natalia Miño; Fernando Muñoz; Antonio González; Josep A Planell; Maria-Pau Ginebra
Journal:  J Mater Sci Mater Med       Date:  2007-02       Impact factor: 3.896

4.  Injectable iron-modified apatitic bone cement intended for kyphoplasty: cytocompatibility study.

Authors:  M D Vlad; L J del Valle; I Poeata; M Barracó; J López; R Torres; E Fernández
Journal:  J Mater Sci Mater Med       Date:  2008-07-15       Impact factor: 3.896

5.  Self-setting calcium orthophosphate formulations.

Authors:  Sergey V Dorozhkin
Journal:  J Funct Biomater       Date:  2013-11-12

6.  Preparation of hydroxyapatite/collagen injectable bone paste with an anti-washout property utilizing sodium alginate. Part 1: influences of excess supplementation of calcium compounds.

Authors:  Taira Sato; Masanori Kikuchi; Mamoru Aizawa
Journal:  J Mater Sci Mater Med       Date:  2017-02-08       Impact factor: 3.896

7.  Remineralized bone matrix as a scaffold for bone tissue engineering.

Authors:  Matthew A Soicher; Blaine A Christiansen; Susan M Stover; J Kent Leach; Clare E Yellowley; Leigh G Griffiths; David P Fyhrie
Journal:  J Biomed Mater Res A       Date:  2014-02-26       Impact factor: 4.396

8.  Eggshell derived brushite bone cement with minimal inflammatory response and higher osteoconductive potential.

Authors:  R Jayasree; T S Sampath Kumar; R Venkateswari; Rakesh P Nankar; Mukesh Doble
Journal:  J Mater Sci Mater Med       Date:  2019-10-03       Impact factor: 3.896

9.  Effects of DCPD cement chemistry on degradation properties and cytocompatibility: comparison of MCPM/β-TCP and MCPM/HA formulations.

Authors:  Daniel L Alge; W Scott Goebel; Tien-Min Gabriel Chu
Journal:  Biomed Mater       Date:  2013-02-22       Impact factor: 3.715

10.  Biodegradable β-tricalcium phosphate cement with anti-washout property based on chelate-setting mechanism of inositol phosphate.

Authors:  Toshiisa Konishi; Shuhei Takahashi; Zhi Zhuang; Kohei Nagata; Minori Mizumoto; Michiyo Honda; Yasuhiro Takeuchi; Hitomi Matsunari; Hiroshi Nagashima; Mamoru Aizawa
Journal:  J Mater Sci Mater Med       Date:  2013-03-08       Impact factor: 3.896

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.